Short Interest in Aterian, Inc. (NASDAQ:ATER) Declines By 18.1%

Aterian, Inc. (NASDAQ:ATERGet Free Report) was the target of a significant drop in short interest during the month of August. As of August 31st, there was short interest totalling 300,500 shares, a drop of 18.1% from the August 15th total of 367,000 shares. Currently, 4.6% of the company’s shares are sold short. Based on an average daily volume of 119,600 shares, the short-interest ratio is presently 2.5 days.

Aterian Price Performance

Shares of NASDAQ ATER opened at $3.17 on Tuesday. Aterian has a 1-year low of $1.90 and a 1-year high of $6.54. The business has a fifty day moving average price of $3.01 and a 200 day moving average price of $2.95. The stock has a market capitalization of $27.20 million, a P/E ratio of -0.38 and a beta of 2.04.

Aterian (NASDAQ:ATERGet Free Report) last released its quarterly earnings results on Thursday, August 8th. The company reported ($0.52) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.64) by $0.12. Aterian had a negative net margin of 18.88% and a negative return on equity of 64.24%. The business had revenue of $27.98 million for the quarter.

Insiders Place Their Bets

In other news, Director William Kurtz sold 8,547 shares of the stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $3.01, for a total value of $25,726.47. Following the sale, the director now directly owns 47,216 shares in the company, valued at $142,120.16. The sale was disclosed in a document filed with the SEC, which is available at this link. In other Aterian news, Director William Kurtz sold 8,547 shares of the business’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $3.01, for a total value of $25,726.47. Following the completion of the sale, the director now directly owns 47,216 shares of the company’s stock, valued at approximately $142,120.16. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CTO Roi Zion Zahut sold 14,050 shares of the stock in a transaction that occurred on Wednesday, September 11th. The stock was sold at an average price of $3.06, for a total value of $42,993.00. Following the completion of the transaction, the chief technology officer now directly owns 201,494 shares in the company, valued at approximately $616,571.64. The disclosure for this sale can be found here. Insiders sold a total of 49,015 shares of company stock valued at $150,562 over the last 90 days. Insiders own 4.70% of the company’s stock.

Hedge Funds Weigh In On Aterian

A hedge fund recently raised its stake in Aterian stock. B. Riley Wealth Advisors Inc. increased its holdings in shares of Aterian, Inc. (NASDAQ:ATERFree Report) by 39.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,750 shares of the company’s stock after buying an additional 7,050 shares during the quarter. B. Riley Wealth Advisors Inc. owned 0.32% of Aterian worth $68,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 7.02% of the company’s stock.

About Aterian

(Get Free Report)

Aterian, Inc, together with its subsidiaries, operates as a technology-enabled consumer products company in North America and internationally. Its platform offers home and kitchen appliances; kitchenware; cooling and air quality appliances, such as dehumidifiers; health and beauty products; and essential oils under the Squatty Potty, hOmeLabs, Mueller, Pursteam, Healing Solutions, and Photo Paper Direct brand names.

Featured Stories

Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.